(603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Implementation Results of Share Repurchase and Share Changes
Filed with SSE · Stock code 603590 · · 3 pages · Chinese
Summary by 6ix AI
Beijing Konruns Pharmaceutical Co., Ltd. announced the results of its share repurchase and changes in share capital. The repurchase was completed within the approved timeframe and adhered to legal regulations. The announcement also details the handling of the repurchased shares and their future use.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Beijing Konruns Pharmaceutical Co., Ltd. on 6ix
Story so far
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Repurchase and Cancellation of Restricted Shares Granted to Certain Incentive Participants but Not Yet Released from Trading Restrictions
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Change of Registered Capital and Amendment to the Articles of Association
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Resolutions of the 7th Meeting of the 5th Board of Directors
Earlier from Beijing Konruns Pharmaceutical
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Notice on Convening the 2nd Extraordinary General Meeting in 2026
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Resolutions of the 7th Meeting of the 5th Board of Directors
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Repurchase and Cancellation of Restricted Shares Granted to Certain Incentive Participants but Not Yet Released from Trading Restrictions
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Change of Registered Capital and Amendment to the Articles of Association
- (603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares
Later from Beijing Konruns Pharmaceutical
All Beijing Konruns Pharmaceutical news releasesFollow Beijing Konruns Pharmaceutical into a list and get an email when it puts out news.
Follow Beijing Konruns Pharmaceutical